Tech Company Financing Transactions
Xanodyne Pharmaceuticals Funding Round
On 7/27/2007, Xanodyne Pharmaceuticals raised $25 million in Series A financing from Aisling Capital, Apax Partners and Blue Chip Venture Company.
Transaction Overview
Company Name
Announced On
7/27/2007
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. The financing was a re-cap round.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
One Riverfront Place
Newport, KY 41071
USA
Newport, KY 41071
USA
Phone
Website
Email Address
Overview
Xanodyne is a specialty pharmaceutical company with commercial and development capabilities for providing better patient care in women's health and pain management.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Natasha Giordano
Chief Financial Officer
Rita O'Connor
Chief Operating Officer
Fabrice Egros
VP - Regulatory Affairs
Thomas Jennings
Browse more venture capital transactions:
Prev: 7/26/2007: Bay Microsystems venture capital transaction
Next: 7/27/2007: PowerFile venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs